Related references
Note: Only part of the references are listed.Toward personalized treatment approaches for non-small-cell lung cancer
Meina Wang et al.
NATURE MEDICINE (2021)
IGF-1R drugs travel from cancer cradle to Graves'
Elie Dolgin
NATURE BIOTECHNOLOGY (2020)
mRNA vaccines - a new era in vaccinology
Norbert Pardi et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Downregulation of PIK3CA via antibody-esiRNA-complexes suppresses human xenograft tumor growth
Nicole Baeumer et al.
PLOS ONE (2018)
Understanding and targeting resistance mechanisms in NSCLC
Julia Rotow et al.
NATURE REVIEWS CANCER (2017)
Antibody-coupled siRNA as an efficient method for in vivo mRNA knockdown
Nicole Baeumer et al.
NATURE PROTOCOLS (2016)
Antibody-Mediated Delivery of Anti-KRAS-siRNA In Vivo Overcomes Therapy Resistance in Colon Cancer
Sebastian Baeumer et al.
CLINICAL CANCER RESEARCH (2015)
Evaluation of multimeric siRNA conjugates for efficient protamine-based delivery into breast cancer cells
Hyundong Yoo et al.
ARCHIVES OF PHARMACAL RESEARCH (2015)
Aggregation and de-aggregation of gold nanoparticles induced by polyionic drugs: spectrofluorimetric determination of picogram amounts of protamine and heparin drugs in the presence of 1000-fold concentration of major interferences
N. Vasimalai et al.
JOURNAL OF MATERIALS CHEMISTRY B (2013)
Insulin Growth Factor-Receptor (IGF-1R) Antibody Cixutumumab Combined with the mTOR Inhibitor Temsirolimus in Patients with Refractory Ewing's Sarcoma Family Tumors
Aung Naing et al.
CLINICAL CANCER RESEARCH (2012)
Understanding the mechanism of protamine in solid lipid nanoparticle-based lipofection: The importance of the entry pathway
Diego Delgado et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2011)
Primary Disseminated Multifocal Ewing Sarcoma: Results of the Euro-EWING 99 Trial
Ruth Ladenstein et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Inhibitory activity of cetuximab on epidermal growth factor receptor mutations in non-small cell lung cancers
Jacqueline F. Doody et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors
EW Song et al.
NATURE BIOTECHNOLOGY (2005)
Small interfering RNAs expressed from a pol III promoter suppress the EWS/Fli-1 transcript in an Ewing sarcoma cell line
T Dohjima et al.
MOLECULAR THERAPY (2003)
Share Paper
